risk reducing salpingo

Related by string. * risking . risked . Risks . risks . RISK : High Risk Warning . Risk Factors section . Key Risk Ranking . heading Risk Factors . Item 1A Risk Factors / reduced . Reducing . reducer . REDUCED . Reduced : reducing greenhouse gas . reducing carbon emissions . reducing CO2 emissions . reducing maternal mortality / : salpingo oophorectomy . bilateral salpingo oophorectomy * *

Related by context. Frequent words. (Click for all words.) 71 oophorectomy 64 lymphadenectomy 64 varicocele 63 ultrasonographic 63 Ischemic 63 radical cystectomy 62 transurethral resection 62 GnRH agonists 62 thyroid nodules 62 nerve sparing 62 Resection 62 radical nephrectomy 61 renal tumors 61 axillary lymph nodes 61 Uterine 61 carotid stenosis 61 colorectal carcinoma 60 BERKELEY CA UroToday.com 60 Angiographic 60 prostatic 60 cystectomy 60 cytological 60 breast carcinoma 60 gynecologic procedures 60 mediastinal 60 thromboprophylaxis 60 Embolization 60 neoadjuvant 60 pericardial effusion 60 extracranial 60 gastrectomy 59 recurrent miscarriage 59 carotid artery stenting 59 thrombophilia 59 clinically localized prostate 59 Thrombolysis 59 POAG 59 paclitaxel eluting stents 59 estimated glomerular filtration 59 valvular 59 ureteral 59 etiologic 59 androgen deprivation 59 neoplastic 59 deep venous thrombosis 59 epithelial ovarian cancer 58 antibiotic prophylaxis 58 retroperitoneal 58 neurocognitive function 58 Preoperative 58 parenchymal 58 Computed tomography 58 sentinel lymph node biopsy 58 sonographic findings 58 serum PSA 58 Chronic Heart Failure 58 lipid lowering agents 58 TURP 58 lymph node dissection 58 PCa 58 adjuvant radiation 58 Ultrasonography 58 glomerular filtration rate 58 intracoronary 58 Intracranial 58 lymphadenopathy 58 fibrinolysis 58 knee arthroplasty 58 lymph node metastasis 58 murine model 58 atypia 57 nonoperative 57 coronary angiogram 57 hepatocellular 57 subclinical hypothyroidism 57 multivariate analyzes 57 MRgFUS 57 Postoperative 57 platelet activation 57 pancreatic adenocarcinoma 57 advanced adenomas 57 thyroid dysfunction 57 platelet reactivity 57 reintervention 57 Hepatic 57 esophagectomy 57 Natalizumab 57 logistic regression analysis 57 malignant neoplasms 57 neoadjuvant therapy 57 postsurgical 57 immunohistochemical 57 venous thrombosis 57 Prognostic 57 serum concentrations 57 thromboembolism 57 strontium ranelate 57 beta blocker therapy 57 secondary hyperparathyroidism 57 contralateral breast cancer 57 LUTS

Back to home page